Dg Health Advanced Relief Eye Drops Solution
NDC Package 55910-361-01
Package Information
Dg Health Advanced Relief Eye Drops (dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline hcl) solution is usesrelieves redness of the eye due to minor eye irritationsas a lubricant to prevent further irritation or to relieve dryness of the eye. This formulation utilizes a solution delivery system. Marketed by Dolgencorp Llc, this product is identified by NDC 55910-361 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 996202 - dextran 70 0.1 % / polyethylene glycol 400 1 % / povidone 1 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution
- RxCUI: 996202 - dextran 70 1 MG/ML / polyethylene glycol 400 10 MG/ML / povidone 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55910 - Dolgencorp Llc
- 55910-361 - Dg Health Advanced Relief Eye Drops
- 55910-361-01 - 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER
- 55910-361 - Dg Health Advanced Relief Eye Drops
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55910-361-01 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 15 ml in 1 bottle, dropper of Dg Health Advanced Relief Eye Drops, a human over the counter drug labeled by Dolgencorp Llc. This solution is formulated for ophthalmic use and contains dextran 70; polyethylene glycol 400; povidone, unspecified; tetrahydrozoline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dolgencorp Llc on January 26, 2020. The current certification is valid through December 31, 2026.
How is this Dolgencorp Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910036101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.